In vitro and in vivo release of cefuroxime axetil from bioactive glass as an implantable delivery system in experimental osteomyelitis

Ceramics International

Volumn 35, Issue 8, 2009, Pages 3207-3216

  Nandi, Samit K ^a   Kundu, Biswanath ^b   Mukherjee, Prasenjit ^a   Mandal, Tapan K ^a   Datta, Someswar ^b   De, Dipak K ^a   Basu, Debabrata ^b  

^a WEST BENGAL UNIVERSITY OF ANIMAL AND FISHERY SCIENCES   (India)

^b CSIR CENTRAL GLASS AND CERAMIC RESEARCH INSTITUTE   (India)

Author keywords

Bioactive glass; In vitro; In vivo; Osteomyelitis; Sustained release

Indexed keywords

ANTI-MICROBIAL ACTIVITY; CARRIER SYSTEMS; CHARACTERISATION; CONCENTRATION OF; CONTROLLED RELEASE DEVICES; DELIVERY SYSTEMS; DRUG CONCENTRATION; EXPERIMENTAL MODELS; EXPERIMENTAL STUDIES; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; FOURIER; FTIR; GLASS MELTING; ICP-AES; IN VITRO; IN VIVO; IN-VIVO TESTS; INDUCTIVELY-COUPLED; MINIMUM INHIBITORY CONCENTRATION; ORTHOPAEDIC SURGERY; OSTEOMYELITIS; POROUS BIOACTIVE GLASS; POROUS BLOCKS; RADIOLOGICAL EVALUATION; STAPHYLOCOCCUS AUREUS; STUDY DESIGN; SUSTAINED RELEASE;

ANIMALS; ANTIBIOTICS; ATOMIC EMISSION SPECTROSCOPY; ATOMIC SPECTROSCOPY; BIOCOMPATIBILITY; BODY FLUIDS; BONE; CONCENTRATION (PROCESS); FEEDBACK AMPLIFIERS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; GLASS CERAMICS; GLASS MANUFACTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INDUCTIVELY COUPLED PLASMA; RADIOLOGY; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION; X RAY DIFFRACTION ANALYSIS;

BIOACTIVE GLASS;

EID: 70349223865     PISSN: 02728842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceramint.2009.05.005     Document Type: Article

References (43)

1. Khan D.S., and Pritzker K.P.H. The pathophysiology of bone infection. Clin. Orthop. 969 (1973) 12-19
2. Cierny 3rd G., Mader J.T., and Penninck J.J. A clinical staging system for adult osteomyelitis. Clin. Orthop. Relat. Res. 414 (2003) 7-24
3. Lazzarini L., Mader J.T., and Calhoun J.H. Osteomyelitis in long bones. J. Bone Joint Surg. 86A (2004) 2305-2318
4. Parsons B., and Strauss E. Surgical management of chronic osteomyelitis. Am. J. Surg. 188 (2004) 57-66
5. Rushton N. Applications of local antibiotic therapy. Eur. J. Surg. 578 Suppl. (1997) 27-30
6. Perry C.R., and Pearson R.L. Local antibiotic delivery in the treatment of bone and joint infections. Clin. Orthop. Relat. Res. 263 (1991) 215-226
7. Lasserre A., and Bajpai P.K. Ceramic drug-delivery devices. Crit. Rev. Ther. Drug Carrier Syst. 15 (1998) 1-56
8. Nelson C.L., McLaren S.G., Skinner R.A., Smeltzer M.S., Thomas J.R., and Olsen K.M. The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulphate tobramycin pellets. J. Orthop. Res. 204 (2002) 643-647
9. Solberg B.D., Gutow A.P., and Baumgaertner M.R. Efficacy of gentamicin-impregnated resorbable hydroxyapatite cement in treating osteomyelitis in a rat model. J. Orthop. Trauma 13 (1999) 102-106
10. McLaren A.C. Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections. Clin. Orthop. Relat. Res. 427 (2004) 101-106
11. Wilson J., and Low S.B. Bioactive ceramics for periodontal treatment: comparative studies in the Patus monkey. J. Appl. Biomater. 3 (1992) 123-129
12. Wilson J., Yu L.T., and Beale B.S. Bone augmentation using Bioglass particulates in dogs: Pilot study. Bioceramics 5 (1993) 139-146
13. Hench L.L., Andersson O.H., and LaTorre G.P. The kinetics of bioactive ceramics, part III: surface reactions for bioactive glasses compared with an inactive glass. Bioceramics 4 (1991) 156-162
14. Hench L.L., Splinter R.J., Allen W.C., and Greenlee Jr. T.K. Bonding mechanisms at the interface of ceramic prosthetic materials. J. Biomed. Mater. Res. 2 (1971) 117-141
15. Gross U., Kinne R., Schmitz H.J., and Strunz V. The response of bone to surface active glass/glass-ceramics. CRC Crit. Rev. Biocompat. 4 (1988) 25-30
16. Chiu F.Y., Chen C.M., Lin C.F.J., and Lo W.H. Cefuroxime impregnated cement in primary total knee arthroplasty. J. Bone Joint Surg. 84A 5 (2002) 759-762
17. Doyle P.J. Glass-making Today (1979), Portcullis Press, UK pp. 139-186
18. Norden C.W. Experimental osteomyelitis: a description of the model. J. Infect. Dis. 122 (1970) 410-418
19. Hench L.L. Bioceramics: from concept to clinic. J. Am. Ceram. Soc. 74 (1991) 1487-1510
20. Hench L.L. Bioceramics: materials characteristics versus in vivo behavior. In: Ducheyne P., and Lemons J.E. (Eds). Proceedings of the Annals of the New York Academy of Sciences, vol. 523. New York (1988) 54-71
21. van Blitterswijk C.A., Grote J.J., Kuypers W., Blok-van Hoek C.J.G., and Daems W.T. Bioreactions at the tissue/hydroxyapatite interface. Biomaterials 6 (1985) 243-251
22. El-Ghannam A., Hamazawy E., and Yehia A. Effect of thermal treatment on bioactive glass microstructure, corrosion behavior, ζ potential and protein adsorption. J. Biomed. Mater. Res. Part A 55 (2001) 387-395
23. Nandi S.K., Kundu B., Datta S., De D.K., and Basu D. The repair of segmental bone defects with porous bioglass: an experimental study in goat. Res. Vet. Sci. 86 (2009) 162-173
24. Hench L.L., and Paschall H.A. Histochemical responses at a biomaterial's interface. J. Biomed. Mater. Res. Symp. 5 (1974) 49-64
25. Nakamura T., Yamamuro T., Higashi S., Kokubo T., and Itoo S. A new glass-ceramic for bone replacement: evaluation of its bonding to bone tissue. J. Biomed. Mater. Res. 19 (1985) 685-698
26. Neo M., Kotani S., Fujita Y., Nakamura T., Yamamuro T., Bando Y., Ohtsuki C., and Kokubo T. Differences in ceramic-bone interface between surface-active ceramics and resorbable ceramics: a study by scanning and transmission electron microscopy. J. Biomed. Mater. Res. 26 (1992) 255-267
27. Annaz B., Hing K.A., Kayser M., Buckland T., and Di Silvio L. Porosity variation in hydroxyapatite and osteoblast morphology: a scanning electron microscopy study. J. Microsc. 215 (2004) 100-110
28. Boyde A., Corsi A., Quarto R., Cancedda R., and Bianco P. Osteoconduction in large macroporous hydroxyapatite ceramic implants: evidence for a complementary integration and disintegration mechanism. Bone 24 (1999) 579-589
29. Hing K.A., Annaz B., Saeed S., Revell P.A., and Buckland T. Microporosity enhances bioactivity of synthetic bone graft substitutes. J. Mater. Sci. Mater. Med. 16 (2005) 467-475
30. Ripamonti U. Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models. Biomaterials 17 (1996) 31-35
31. Joosten U., Joist A., Frebel T., Brandt B., Diederichs S., and von Eiff C. Evaluation of an in situ setting injectable calcium phosphate as a new carrier material for gentamicin in the treatment of chronic osteomyelitis: studies in vitro and in vivo. Biomaterials 25 18 (2004) 4287-4295
32. Dominguesa Z.R., Cortés M.E., Gomesa T.A., Dinizb H.F., Freitasb C.S., Gomesb J.B., Fariac A.M.C., and Sinisterra R.D. Bioactive glass as a drug delivery system of tetracycline and tetracycline associated with β-cyclodextrin. Biomaterials 25 2 (2004) 327-333
33. Itokazu M., Ohno T., Tanemori T., Wada E., Kato N., and Watanabe K. Antibiotic-loaded hydroxyapatite blocks in the treatment of experimental osteomyelitis in rats. J. Med. Microbiol. 46 9 (1997) 779-783
34. Sanchez E., Baro M., Soriano I., Perera A., and Evora C. In vivo-in vitro study of biodegradable and osteointegrable gentamicin bone implants. Eur. J. Pharm. Biopharm. 52 2 (2001) 151-158
35. Woodward J.C., and Riser W.H. Morphology of fracture non union and osteomyelitis. Vet. Clin. North Am. (Small Anim. Prac.) 21 (1991) 313-344
36. Fossum T.W., and Hulse D.A. Osteomyelitis. Semin. Vet. Med. Surg. (Small Anim.) 7 (1992) 85-97
37. M. Hoque, Post-traumatic osteomyelitis: its incidence in fracture case and experimental studies in goats, Ph.D. Thesis, Indian Veterinary Research Institute, Izatnagar, India, 1996.
38. Korkusuz F., Korkusuz P., Eksioglu F., Gürsel I., and Hasi{dotless}rci{dotless} V. In vivo response to biodegradable controlled antibiotic release systems. J. Biomed. Mater. Res. 55 2 (2001) 217-228
39. Wise R., Andrews J.M., and Hancox J. In vitro activity of Cefotetan, a new cephamycin derivative, compared with that of other β-lactum compounds. Antimicrob. Agents Chemother. 21 3 (1982) 486-491
40. Calhoun J.H., and Mader J.T. Antibiotic beads in the management of surgical infections. Am. J. Surg. 157 (1989) 443-449
41. Gordon I., and Chiu B.J. Treatment of infected non-unions and segmental defects of the tibia with staged microvascular muscle transplantation and bone grafting. J. Bone Joint Surg. 70A (1988) 377-386
42. Barza M. Anatomical barriers for antimicrobial agents. Eur. J. Clin. Microbiol. Infect. Dis. 12 Suppl. 1 (1993) 31-35
43. Walenkamp G.H.I.M., Vree T.B., and Van Rens T.J.G. Gentamicin-PMMA beads. Pharmacokinetic and nephrotoxicological study. Clin. Orthop. 205 (1986) 171-183